Trial Profile
An Open-Label Study to Evaluate the Effects of Repeat Dosing of Esomeprazole on the Pharmacokinetics of SB-751689 in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Ronacaleret (Primary) ; Esomeprazole
- Indications Gastrointestinal disorders; Osteoporosis; Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 18 Jun 2008 Status changed from initiated to completed as reported by ClinicalTrials.gov.
- 03 Sep 2007 New trial record.